OpenURL Connection Search

Select item for more details and to access through your institution.

Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.
Published in:
Cancers, 2024, v. 16, n. 9, p. 1707, doi. 10.3390/cancers16091707
By:
- Denu, Ryan A.;
- Joseph, Cissimol P.;
- Urquiola, Elizabeth S.;
- Byrd, Precious S.;
- Yang, Richard K.;
- Ratan, Ravin;
- Zarzour, Maria Alejandra;
- Conley, Anthony P.;
- Araujo, Dejka M.;
- Ravi, Vinod;
- Nassif Haddad, Elise F.;
- Nakazawa, Michael S.;
- Patel, Shreyaskumar;
- Wang, Wei-Lien;
- Lazar, Alexander J.;
- Somaiah, Neeta
Publication type:
Article
The Future of Targeted Therapy for Leiomyosarcoma.
Published in:
Cancers, 2024, v. 16, n. 5, p. 938, doi. 10.3390/cancers16050938
By:
- Denu, Ryan A.;
- Dann, Amanda M.;
- Keung, Emily Z.;
- Nakazawa, Michael S.;
- Nassif Haddad, Elise F.
Publication type:
Article
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Published in:
Cancers, 2024, v. 16, n. 5, p. 904, doi. 10.3390/cancers16050904
By:
- Thirasastr, Prapassorn;
- Sutton, Thomas L.;
- Joseph, Cissimol P.;
- Lin, Heather;
- Amini, Behrang;
- Mayo, Skye C.;
- Araujo, Dejka;
- Benjamin, Robert S.;
- Conley, Anthony P.;
- Livingston, John A.;
- Ludwig, Joseph;
- Patel, Shreyaskumar;
- Ratan, Ravin;
- Ravi, Vinod;
- Zarzour, Maria A.;
- Nassif Haddad, Elise F.;
- Nakazawa, Michael S.;
- Zhou, Xiao;
- Heinrich, Michael C.;
- Somaiah, Neeta
Publication type:
Article
Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth.
Published in:
Nature Communications, 2016, v. 7, n. 2, p. 10539, doi. 10.1038/ncomms10539
By:
- Nakazawa, Michael S.;
- Eisinger-Mathason, T. S. Karin;
- Sadri, Navid;
- Ochocki, Joshua D.;
- Gade, Terence P. F.;
- Amin, Ruchi K.;
- Simon, M. Celeste
Publication type:
Article
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.
Published in:
Rare Tumors, 2024, p. 1, doi. 10.1177/20363613241271669
By:
- Nakazawa, Michael S;
- Livingston, J Andrew;
- Zarzour, Maria A;
- Bishop, Andrew J;
- Ratan, Ravin;
- Ludwig, Joseph A;
- Araujo, Dejka M;
- Somaiah, Neeta;
- Ravi, Vinod;
- Nassif, Elise F;
- Roland, Christina L;
- Lazar, Alexander J;
- Guadagnolo, B Ashleigh;
- Harrison, Douglas J;
- Benjamin, Robert S;
- Patel, Shreyaskumar R;
- Conley, Anthony P
Publication type:
Article
Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.
Published in:
International Journal of Cancer, 2013, v. 132, n. 1, p. 29, doi. 10.1002/ijc.27666
By:
- Kim, Yeo‐Jung;
- Lee, Hae‐June;
- Kim, Tae‐Min;
- Eisinger‐Mathason, T.S. Karin;
- Zhang, Alexia Y.;
- Schmidt, Benjamin;
- Karl, Daniel L.;
- Nakazawa, Michael S.;
- Park, Peter J.;
- Simon, M. Celeste;
- Yoon, Sam S.
Publication type:
Article

Found: 6

Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.

The Future of Targeted Therapy for Leiomyosarcoma.

Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?

Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth.

Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.

Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.